Scott Waldman
Scott Waldman is an American pharmacologist and oncologist known for his significant contributions to the field of cancer research. He is currently the Chair of the Department of Pharmacology and Experimental Therapeutics at the Sidney Kimmel Medical College at Thomas Jefferson University.
Early Life and Education[edit | edit source]
Scott Waldman was born and raised in the United States. He completed his undergraduate studies in biology at the University of Pennsylvania, before pursuing his MD and PhD at the Johns Hopkins University School of Medicine. His PhD research focused on molecular biology and biochemistry, laying the groundwork for his future career in pharmacology and oncology.
Career[edit | edit source]
After completing his education, Waldman joined the faculty at Thomas Jefferson University. He has since held numerous positions within the institution, including Director of the Division of Clinical Pharmacology and Vice Chair of the Department of Medicine. In 2008, he was appointed Chair of the Department of Pharmacology and Experimental Therapeutics.
Waldman's research primarily focuses on the role of guanylyl cyclase C (GCC) in colorectal cancer. His work has led to the development of a GCC-targeted diagnostic test for colorectal cancer, which is currently in clinical trials. He has also contributed to the understanding of the role of GCC in regulating intestinal fluid and electrolyte balance, which has implications for the treatment of diarrheal diseases.
Awards and Honors[edit | edit source]
Throughout his career, Waldman has received numerous awards and honors for his contributions to pharmacology and oncology. These include the American Association for Cancer Research Outstanding Investigator Award and the American Society for Clinical Pharmacology and Therapeutics Rawls-Palmer Progress in Medicine Award.
Publications[edit | edit source]
Waldman has authored or co-authored over 300 peer-reviewed articles in prestigious scientific journals. His work has been cited thousands of times, reflecting the significant impact of his research on the field of pharmacology and oncology.
See Also[edit | edit source]
References[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
